Long-term efficacy of infliximab for treating takayasu arteritis

Israel Medical Association Journal

Volumn 14, Issue 12, 2012, Pages 771-773

  Killinger, Zdenko ^a   Ĉierny, Daniel ^a   Jackuliak, Peter ^a   Zelinkova, Zuzana ^a   Rovensky, Jozef ^b   Payer, Juraj ^a  

^a UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

^b NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

Author keywords

Infliximab; Takayasu arteritis; Tumor necrosis factor alpha (TNF ) inhibition; Vasculitis

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CLOPIDOGREL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; SULODEXIDE;

ABSENCE OF SIDE EFFECTS; ADULT; ALOPECIA; ANEMIA; ANGIOGRAPHY; AORTA ARCH SYNDROME; ARM PAIN; ARTERY OCCLUSION; ARTHRALGIA; ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG EFFICACY; DYSPEPSIA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEARTBURN; HUMAN; HYPERTENSION; HYPERTRANSAMINASEMIA; LIMB WEAKNESS; METRORRHAGIA; NEPHROTOXICITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; ULTRASOUND; WEAKNESS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; TAKAYASU ARTERITIS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84871876695     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Caspary L. Vasculitides of large vessels. Vasa 2011; 40 (2): 89-98.
2. Comarmond C, Plaisier E, Dahan K, et al. Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature. Autoimmun Rev 2012; 11(9): 678-84.
3. Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 2004; 50 (7): 2296-304.
4. Mekinian A, Néel A, Sibilia J, et al; Club Rhumatismes et Inflammation, French Vasculitis Study Group and Société Nationale Française de Médecine Interne. Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study. Rheumatology (Oxford) 2012; 51 (5): 882-6.
5. Schmidt J, Kermani TA, Bacani AK, Crowson CS, Matteson EL, Warrington KJ. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup. Arthritis Care Res (Hoboken) 2012;64 (7): 1079-83.